When it comes to drug manufacturing we offer everything to stay compliant each step of the way. Our robust characterization technologies such as microfluidics, detection, and assay platforms, as well as spectroscopy solutions, support the evaluation of monoclonal antibodies, recombinant proteins, viral therapeutics, including vaccines and repurposed drugs during the Chemistry Manufacturing and Controls (CMC) protocols in drug development and commercial manufacturing QA/QC batch release.

At PerkinElmer, we are proud to offer end-to-end solutions including a suite of assay platforms as primary or orthogonal technologies to overcome the challenges in methods development and validation related to biologics manufacturing.